THE REGENTS OF THE UNIVERSITY OF COLORADO
RALEIGH, New York
Total Received
$1.70B
Total Awards
482
State
New York
Last Updated
Mar 20, 2026
Yearly Funding Trend
$1.47B24
$199.8M25
$23.5M26
Top 50 Awards to THE REGENTS OF THE UNIVERSITY OF COLORADO
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P30CA006516_075 NCI EARLY CAREER CANCER CLINICAL INVESTIGATOR AWARD - PROJECT SUMMARY/ABSTRACT WITH SUPPORT FROM THE NCI EARLY CAREER INVESTIGATOR AWARD, DR. RIFAQUAT RAHMAN AIMS TO FOCUS ON THE… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | MA-90 | 2024 | $223,028,233 |
ASST_NON_U10CA180794_075 ECOG-ACRIN NETWORK GROUP STATISTICS AND DATA MANAGEMENT CENTER - THIS GRANT WILL PROVIDE SUPPORT FOR THE STATISTICS AND DATA MANAGEMENT CENTER (SDMC) OF THE ECOG- ACRIN CANCER RES… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $92,836,256 |
ASST_NON_P01CA066996_075 DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES IN HUMAN LEUKEMIAS - OVERALL PROGRAM SUMMARY THE OVERALL GOAL OF THIS PROGRAM IS TO IMPROVE OUTCOMES IN THE TREATMENT OF HUMAN LEUKEMIA… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | MA-90 | 2024 | $34,802,376 |
ASST_NON_P50CA100707_075 SPORE IN MULTIPLE MYELOMA - OVERALL SUMMARY THE DANA FARBER/HARVARD CANCER CENTER (DF/HCC) MULTIPLE MYELOMA (MM) SPORE RENEWAL APPLICATION CONSISTS OF 3 RESEARCH PROJECTS AND 3 CO… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | MA-90 | 2025 | $33,209,515 |
ASST_NON_P50CA127003_075 DANA FARBER/ HARVARD CANCER CENTER SPORE IN GASTROINTESTINAL CANCER - PROJECT SUMMARY THIS IS A COMPETITIVE RENEWAL APPLICATION FOR A SPORE IN GASTROINTESTINAL (GI) CANCERS ORIGIN… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2024 | $30,907,185 |
ASST_NON_U24CA233243_075 HUMAN TUMOR ATLAS NETWORK: DATA COORDINATING CENTER - PROJECT SUMMARY/ABSTRACT THE HUMAN TUMOR ATLAS NETWORK (HTAN) SEEKS TO IMPROVE OUR UNDERSTANDING OF THE IMPORTANT TRANSITIONS… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | MA-90 | 2024 | $28,562,644 |
ASST_NON_P01CA155258_075 INTEGRATIVE ONCOGENOMICS OF MULTIPLE MYELOMA - PROJECT SUMMARY – OVERALL PROGRAM DANA-FARBER CANCER INSTITUTE THIS RENEWAL APPLICATION STEMS FROM OUR SUCCESSFUL RENEWAL OF OUR PRO… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $27,680,811 |
ASST_NON_P50CA168504_075 DANA-FARBER/HARVARD CANCER CENTER SPORE IN BREAST CANCER - PROJECT SUMMARY THE DANA-FARBER/HARVARD CANCER CENTER (DF/HCC) SPORE IN BREAST CANCER SEEKS TO IMPROVE THE UNDERSTANDING… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2025 | $25,026,599 |
ASST_NON_U54CA156732_075 2/2 THE UNIVERSITY OF MASSACHUSETTS, BOSTON - DANA-FARBER/HARVARD CANCER CENTER U54 COMPREHENSIVE PARTNERSHIP FOR CANCER DISPARITIES RESEARCH - THE UNIVERSITY OF MASSACHUSETTS BOS… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2024 | $24,453,107 |
ASST_NON_UM1CA186709_075 DANA-FARBER/HARVARD CANCER CENTER EXPERIMENTAL THERAPEUTICS CLINICAL TRIALS NETWORK SITE (DF/HCC ETCTN SITE) - THE NCI-DESIGNATED DANA-FARBER/HARVARD CANCER CENTER (DF/HCC) INCLUD… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $23,631,028 |
ASST_NON_P01CA154303_075 PROTEIN KINASE THERAPEUTIC TARGETS FOR NON-SMALL CELL LUNG CARCINOMA - LUNG CANCER IS THE LEADING CAUSE OF CANCER DEATH IN THE UNITED STATES AND WORLD-WIDE, WITH OVER 85% OF CASES… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | BOSTON, MA-07 | 2024 | $17,803,632 |
ASST_NON_P01CA206978_075 COMPREHENSIVE DISSECTION OF THE CLL GENOME & PHENOME TO IMPROVE PATIENT OUTCOMES - OVERALL ABSTRACT ALTHOUGH WE HAVE MADE GREAT STRIDES IN OUR UNDERSTANDING OF THE BIOLOGY AND TRE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $16,967,366 |
ASST_NON_U24CA224331_075 CANCER IMMUNE MONITORING AND ANALYSIS CENTER - SUMMARY BECAUSE CANCER IMMUNOTHERAPY CONSTITUTES ONE OF THE MOST TRANSFORMATIVE THERAPEUTIC MOVEMENTS OVER THE HISTORY OF CANCER TRE… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | BOSTON, MA-07 | 2024 | $16,455,371 |
ASST_NON_P01AI143565_075 BIOLOGY AND STRUCTURE OF PMHC RECEPTORS FUNCTIONING AS MECHANOSENSORS IN THE [ALPHA][BETA] T-CELL LINEAGE - OVERALL SUMMARY T LYMPHOCYTES UTILIZED T CELL RECEPTORS (TCRS) TO D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | MA-90 | 2024 | $14,830,426 |
ASST_NON_P01CA229092_075 IMMUNE MODULATION AFTER ALLOGENEIC HCT - PROGRAM SUMMARY ALTHOUGH ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) PROVIDES CURATIVE THERAPY FOR MANY PATIENTS WITH HEMATOLOGIC… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2026 | $13,827,923 |
ASST_NON_U2CCA233195_075 THE CELLULAR GEOGRAPHY OF THERAPEUTIC RESISTANCE IN CANCER - MOST PATIENTS WHO DIE FROM CANCER DO SO BECAUSE THEIR CANCER IS RESISTANT TO AVAILABLE THERAPIES, EITHER INTRINSICALLY… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | BOSTON, MA-07 | 2024 | $13,576,522 |
ASST_NON_U54CA231637_075 THE CENTER FOR THERAPEUTIC TARGETING OF EWS-ONCOPROTEINS - PROJECT SUMMARY: OVERALL THE PRIMARY SCIENTIFIC FOCUS OF THIS CENTER IS TO UNDERSTAND THE MOLECULAR UNDERPINNINGS OF EWS… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2024 | $13,203,098 |
ASST_NON_R35CA197583_075 DISSECTING AND TARGETING DEREGULATED MITOCHONDRIAL APOPTOSIS IN HUMAN CANCER - PROJECT SUMMARY/ABSTRACT BCL-2 PROTEINS PARTICIPATE IN A DYNAMIC INTERACTION NETWORK THAT DETERMINES… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $11,425,117 |
ASST_NON_R35CA197568_075 LUNG ADENOCARCINOMA: FROM GENOME ALTERATIONS TO THERAPEUTIC DISCOVERY - PROJECT SUMMARY THE INTRODUCTION OF NEW TARGETED THERAPIES AND IMMUNOTHERAPIES HAS LED TO SIGNIFICANT DECRE… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BOSTON, MA-07 | 2024 | $11,378,575 |
ASST_NON_R35CA197623_075 TARGETING INTRATUMOR HETEROGENEITY IN BREAST CANCER - PROJECT SUMMARY: BREAST CANCER IS THE MOST COMMON CANCER AND THE LEADING CAUSE OF CANCER DEATHS IN WOMEN WORLD- WIDE. WHILE T… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $11,353,199 |
ASST_NON_P50CA240243_075 DANA FARBER/HARVARD CANCER CENTER OVARIAN CANCER SPORE GRANT - PROJECT SUMMARY (OVERALL) THE OVERALL SECTION OF THIS OVARIAN CANCER SPORE APPLICATION DESCRIBES THE BACKGROUND, SP… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | MA-90 | 2024 | $11,294,190 |
ASST_NON_T32CA009172_075 PHYSICIAN SCIENTIST TRAINING IN CANCER RESEARCH - WITH THIS COMPETITIVE RENEWAL APPLICATION, WE ARE SEEKING FIVE YEARS OF SUPPORT FOR A TRAINING PROGRAM WITH THE NEW TITLE OF “PHY… | Department of Health and Human Services National Institutes of Health | 93.398 CANCER RESEARCH MANPOWER | BOSTON, MA-07 | 2024 | $11,035,068 |
ASST_NON_P50CA206963_075 SPORE IN MYELOID MALIGNANCIES - OVERALL ABSTRACT THE OVERALL GOAL OF THIS SPORE IN MYELOID MALIGNANCIES IS TO TAKE ADVANTAGE OF OUR INCREASED UNDERSTANDING OF THE GENETIC AND MOLE… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2024 | $10,600,056 |
ASST_NON_P01HL158505_075 MECHANISMS AND THERAPY OF CHRONIC GRAFT-VS.-HOST DISEASE - SUMMARY CHRONIC GVHD (CGVHD) IS THE MAJOR CAUSE OF LATE MORBIDITY, MORTALITY AND COMPROMISED ORGAN FUNCTION AFTER ALLOGE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | BOSTON, MA-07 | 2024 | $10,320,200 |
ASST_NON_R35CA210057_075 INTEGRATING TARGETED THERAPY AND IMMUNOTHERAPY TO BREAK THROUGH CANCER - PROJECT SUMMARY/ABSTRACT RESEARCH IN OUR LABORATORY IS CENTERED ON UNDERSTANDING THE DIVERSE SIGNALING NET… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $9,800,368 |
ASST_NON_R35CA210068_075 THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR GENE AND KIDNEY CANCER: INSIGHTS INTO OXYGEN SENSING AND TREATING CANCERS CAUSED BY UNDRUGGABLE MUTATIONS - VHL TUMOR SUPPRESSOR PROTEIN (PV… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $9,761,992 |
ASST_NON_R01CA155010_075 PERSONAL TUMOR NEOANTIGENS FOR IMMUNITY AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA - PROJECT SUMMARY PERSONAL NEOANTIGENS HAVE BEEN CONCEPTUALIZED AS OPTIMAL TUMOR ANTIGENS BUT THEIR BR… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $9,539,320 |
ASST_NON_R01AI052014_075 HIV-1 PREINTEGRATION TRAFFICKING AND NUCLEAR LOCALIZATION - PROJECT SUMMARY THIS LONGSTANDING NIH GRANT OVER ITS LIFETIME HAS MADE SEMINAL DISCOVERIES ON THE MECHANISMS OF INTRANU… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | MA-90 | 2024 | $9,483,666 |
ASST_NON_R35CA197588_075 ROLE OF PHOSPHOINOSITIDES AND PROTEIN KINASES IN THE CONTROL OF CANCER METABOLISM - PROJECT SUMMARY/ABSTRACT PREVIOUS WORK FUNDED BY THIS R35 GRANT LED TO THE DISCOVERY THAT ONCOG… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $9,179,621 |
ASST_NON_P50CA265826_075 DANA FARBER/HARVARD CANCER CENTER SPORE IN LUNG CANCER - THIS APPLICATION IS A RESUBMISSION OF A SPECIALIZED PROGRAM OF RESEARCH EXCELLENCE (SPORE) IN LUNG CANCER ORIGINATING FROM… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2024 | $9,074,410 |
ASST_NON_UH3AG060626_075 ADMINISTRATIVE SUPPLEMENT TO IMPROVING ADVANCE CARE PLANNING IN ONCOLOGY: A PRAGMATIC, CLUSTER-RANDOMIZED TRIAL INTEGRATING PATIENT VIDEOSAND CLINICIAN COMMUNICATION TRAINING - PR… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | BOSTON, MA-07 | 2025 | $9,074,217 |
ASST_NON_UM1CA233080_075 SIMPRO RESEARCH CENTER: INTEGRATION AND IMPLEMENTATION OF PROS FOR SYMPTOM MANAGEMENT IN ONCOLOGY PRACTICE - PROJECT SUMMARY IN 2018, MORE THAN 1.7 MILLION AMERICANS WILL RECEIVE… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | BOSTON, MA-07 | 2025 | $9,045,978 |
ASST_NON_R37AI039394_075 BIOCHEMICAL MECHANISM OF HIV DNA INTEGRATION - PROJECT SUMMARY/ABSTRACT HIV/AIDS REMAINS A DEBILITATING DISEASE GLOBALLY, WITH INFECTIONS AMONG YOUNG ADULTS IN THE US IN RECENT YE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | MA-90 | 2024 | $8,912,429 |
ASST_NON_P01CA233412_075 INFORMED COMBINATION STRATEGIES FOR PERIPHERAL T-CELL LYMPHOMAS - PROJECT SUMMARY DESPITE ADVANCES IN THE TREATMENT OF MANY HEMATOLOGIC MALIGNANCIES, PATIENTS WITH PERIPHERAL T-CE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | MA-90 | 2025 | $8,725,418 |
ASST_NON_P01CA250959_075 NEW THERAPEUTIC VULNERABILITIES IN BREAST CANCER - PROJECT SUMMARY/ABSTRACT THIS PROPOSAL DESCRIBES THE EXISTING AND PROPOSED FUTURE ACTIVITIES OF A CONSORTIUM OF THREE RESEARCH G… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $8,630,014 |
ASST_NON_UM1HG011989_075 MOLECULAR PHENOTYPING OF ~100,000 CODING VARIANTS ACROSS MENDELIAN DISEASE GENES - ABSTRACT THE LAST FOUR DECADES HAVE PRODUCED AN ENORMOUS CATALOG OF HUMAN GENOMIC VARIANTS WHICH… | Department of Health and Human Services National Institutes of Health | 93.172 HUMAN GENOME RESEARCH | BOSTON, MA-07 | 2024 | $8,292,746 |
ASST_NON_P01CA203655_075 HUMAN CANCER SUPPRESSOR FUNCTIONS OF PROTEIN PHOSPHATASE 2A - SUMMARY THIS PROGRAM ENCOMPASSES THREE TIGHTLY CONNECTED THEMES. THE PRIMARY THEME IS CENTERED ON PROTEIN PHOSPHATAS… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $8,021,103 |
ASST_NON_U01CA176058_075 THE DANA-FARBER CANCER INSTITUTE CANCER TARGET DISCOVERY AND DEVELOPMENT CENTER - ABSTRACT INTERNATIONAL EFFORTS TO CHARACTERIZE CANCER GENOMES NOW PROVIDE US WITH AN INITIAL VIEW… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | BOSTON, MA-07 | 2024 | $7,841,043 |
ASST_NON_U01CA210171_075 ALTERED METABOLISM AND MACHINE LEARNING FOR PANCREATIC CANCER EARLY DETECTION - PROJECT SUMMARY PANCREATIC CANCER IS THE 3RD LEADING CAUSE OF CANCER DEATH IN THE UNITED STATES. TH… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | MA-90 | 2024 | $7,839,087 |
ASST_NON_UG1CA233180_075 NCTN LEAD ACADEMIC PARTICIPATING SITE AT DANA-FARBER/PARTNERS CANCER CARE - PROJECT SUMMARY THIS GRANT SUPPORTS NETWORK LEAD ACADEMIC PARTICIPATING SITE (NLAPS) AT DANA-FARBER/PAR… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $7,630,727 |
ASST_NON_R35CA242461_075 STRUCTURE, MECHANISM, AND PHARMACOLOGY OF BRAF AND ITS PARTNERS IN THE RAS/RAF/MAP KINASE PATHWAY - ABSTRACT THE RAS/MAP KINASE PATHWAY IS ABERRANTLY ACTIVATED IN A WIDE VARIETY… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $7,379,880 |
ASST_NON_R35CA210030_075 INTEGRATING TRANSFORMING APPROACHES TO IDENTIFY AND TARGET NEW VULNERABILITIES IN CANCER - SUMMARY THE LAST DECADE HAS SEEN AN UNPARALLELED PACE OF CANCER-FOCUSED DISCOVERY ENABLE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $7,318,282 |
ASST_NON_R35CA210064_075 MECHANISMS AND VULNERABILITIES OF ABERRANT TRANSCRIPTIONAL ENHANCERS IN CANCER - PROJECT SUMMARY/ABSTRACT MANY IMPORTANT ONCOGENES IN HUMAN CANCERS HAVE NORMAL CODING SEQUENCES A… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BOSTON, MA-07 | 2024 | $7,272,064 |
ASST_NON_R01CA188446_075 A NOVEL FLAT-PANEL DETECTOR FOR ADVANCED ON-BOARD RADIATION THERAPY IMAGING - PROJECT SUMMARY DESPITE RECENT TECHNOLOGICAL ADVANCES, ON-TREATMENT IMAGING FOR RADIOTHERAPY PROCEDUR… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | MA-90 | 2024 | $7,237,903 |
ASST_NON_R35CA232128_075 IDENTIFICATION OF NOVEL ONCOGENIC SIGNALING PATHWAYS USING VIRAL PERTURBATIONS - PROJECT SUMMARY MERKEL CELL CARCINOMA (MCC) IS A PRIMARY NEUROENDOCRINE CARCINOMA OF THE SKIN; A… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BOSTON, MA-07 | 2024 | $7,195,535 |
ASST_NON_R35CA220497_075 DEVELOPMENT OF COMBINATION THERAPIES TO DELAY/PREVENT ACQUIRED DRUG RESISTANCE - PROJECT SUMMARY THE USE OF GENOTYPE DIRECTED PRECISION THERAPIES, INCLUDING EPIDERMAL GROWTH FACTO… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | MA-90 | 2024 | $7,165,197 |
ASST_NON_R35CA231945_075 MAXIMIZING THE EFFECTIVENESS OF PI3K INHIBITORS IN THE TREATMENT OF PTEN NULL CANCERS - PROJECT SUMMARY/ABSTRACT IN STUDYING THE PI3 KINASE ISOFORM DEPENDENCE OF DIFFERENT TUMOR T… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BOSTON, MA-07 | 2024 | $7,129,589 |
ASST_NON_T32CA136432_075 RESEARCH TRAINING IN PEDIATRIC ONCOLOGY - PROJECT SUMMARY/ABSTRACT THIS IS A COMPETITIVE RENEWAL APPLICATION FOR TRAINING GRANT SUPPORT IN PEDIATRIC ONCOLOGY. THE GOAL OF THIS T32… | Department of Health and Human Services National Institutes of Health | 93.398 CANCER RESEARCH MANPOWER | MA-90 | 2024 | $7,061,692 |
ASST_NON_P50CA272390_075 DF/HCC PROSTATE SPORE - THE DANA-FARBER/HARVARD CANCER CENTER (DF/HCC) SPORE IN PROSTATE CANCER SEEKS TO IMPROVE THE UNDERSTANDING AND TREATMENT OF PROSTATE CANCER USING A HIGHLY… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BOSTON, MA-07 | 2024 | $7,058,769 |
ASST_NON_U24HG004059_075 BIOCONDUCTOR: AN OPEN-SOURCE, OPEN-DEVELOPMENT COMPUTING RESOURCE FOR GENOMICS - PROJECT SUMMARY BIOCONDUCTOR IS A PROJECT DEDICATED TO THE ANALYSIS AND INTERPRETATION OF HIGH TH… | Department of Health and Human Services National Institutes of Health | 93.172 HUMAN GENOME RESEARCH | BOSTON, MA-07 | 2024 | $6,999,640 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→Federal Programs (CFDA)
View All→12345678910
93.397 — CANCER CENTERS SUPPORT GRANTS$392.9M
93.395 — CANCER TREATMENT RESEARCH$381.0M
93.396 — CANCER BIOLOGY RESEARCH$170.4M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$125.0M
93.353 — 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT$124.1M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$95.4M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$78.3M
93.398 — CANCER RESEARCH MANPOWER$63.3M
93.394 — CANCER DETECTION AND DIAGNOSIS RESEARCH$57.9M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$54.4M
Source: USAspending.gov · All Recipients · New York